ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633275 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633275; 2) Community: the network communities that were significantly associated with the response to NSC 633275; 3) Molecule: the relationships between components within communities and NSC 633275; 4) MDR: the compounds that were significantly associated with the NSC 633275.

NSC Compound Enrichment Correlation
NSC 635450 Null 0.0430505868034761 0.66086759
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.0430505868034761 0.44394431
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0430505868034761 0.4232334
NSC 644919 Null 0.0430505868034761 0.36692212
NSC 645389 Null 0.0430505868034761 0.42885772
NSC 654509 Pirarubicin HCl 0.0430505868034761 0.24786135
NSC 656210 Null 0.0430505868034761 0.35774606
NSC 661940 2-(2-chloroethoxy)naphthazarin 0.0430505868034761 0.095821226
NSC 661941 2-(3-chloropropyloxy)naphthazarin 0.0430505868034761 0.23403749
NSC 665564 Null 0.0430505868034761 0.4316011
Total:113  Current:95    [First] [Prev] [Next] [Last]